Vanguard Capital Management’s Citius Oncology CTOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$552K Hold
546,325
– – ﹤0.01% 3671
2026
Q2
$355K Buy
546,325
+11,501
+2% +$9.16K ﹤0.01% 3766
2026
Q1
$332K Buy
+534,824
New +$537K ﹤0.01% 3732

Other funds holding CTOR

Vanguard Capital Management's CTOR Position: Q3 2026 in Review

Vanguard Capital Management held its Citius Oncology (CTOR) position steady in Q3 2026 at 546,325 shares worth $552K. The position accounts for ﹤0.01% of the portfolio, ranked #3671.

Vanguard Capital Management first reported a position in CTOR in Q1 2026 and has held it in 3 quarters since. 22 funds tracked by Wall St. Rank hold CTOR as of Q3 2026.

  • Vanguard Capital Management held 546,325 shares of Citius Oncology worth $552K as of Q3 2026.
  • Vanguard Capital Management left its Citius Oncology share count unchanged in Q3 2026.
  • Citius Oncology made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3671 holding.
  • Vanguard Capital Management first reported a position in Citius Oncology in Q1 2026 and has held it in 3 quarters since.
  • 22 funds tracked by Wall St. Rank held Citius Oncology as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.